Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1BR8

IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN

1BR8 の概要
エントリーDOI10.2210/pdb1br8/pdb
分子名称PROTEIN (ANTITHROMBIN-III), PROTEIN (PEPTIDE) (3 entities in total)
機能のキーワードserpins, antithrombin, binary-complex, heparin, polymerisation, thrombosis, emphysema, cirrhosis, blood clotting
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Secreted, extracellular space: P01008
タンパク質・核酸の鎖数3
化学式量合計99291.23
構造登録者
Skinner, R.,Chang, W.S.W.,Jin, L.,Pei, X.Y.,Huntington, J.A.,Abrahams, J.P.,Carrell, R.W.,Lomas, D.A. (登録日: 1998-08-26, 公開日: 1998-09-02, 最終更新日: 2024-11-06)
主引用文献Skinner, R.,Chang, W.S.,Jin, L.,Pei, X.,Huntington, J.A.,Abrahams, J.P.,Carrell, R.W.,Lomas, D.A.
Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.
J.Mol.Biol., 283:9-14, 1998
Cited by
PubMed Abstract: The crystal structure of a binary complex of human antithrombin with a peptide of the same sequence as its reactive loop (P14-P3) has been determined at 2.9 A. The peptide binds as the middle strand s4A in the A beta-sheet, homologously to that of the reactive loop in the latent and cleaved forms of antithrombin. Peptide binding results in the complete expulsion of the hinge region of the loop from the A beta-sheet although the conformation differs from that of heparin-activated antithrombin. The 36-fold increase in the rate of reaction of the binary complex with factor Xa indicates that full loop expulsion alone is not sufficient for complete heparin activation of antithrombin but that this is also dependent on the overall conformation of the molecule. Previous studies have demonstrated that reactive loop peptides can block or reverse the polymerisation of serpins associated with cirrhosis and thrombosis. The antithrombin binary complex structure defines the precise localisation of the blocking peptide in a serpin and provides the basis for rational drug design for mimetics that will prevent polymerisation in vivo and so ameliorate the associated disease.
PubMed: 9761669
DOI: 10.1006/jmbi.1998.2083
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.9 Å)
構造検証レポート
Validation report summary of 1br8
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon